These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6307891)

  • 1. Effects of novel lipoxygenase products on migration of eosinophils and neutrophils in vitro.
    Udén AM; Palmblad J; Lindgren JA; Malmsten C
    Int Arch Allergy Appl Immunol; 1983; 72(1):91-3. PubMed ID: 6307891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
    Palmblad J; Udén AM; Friberg I; Ringertz B; Rådmark O; Lindgren JA; Hansson G; Malmsten CL
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():25-31. PubMed ID: 6303087
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
    McEwen BJ; Wilcock BP; Eyre P
    Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20-Hydroxy- and 20-carboxy-leukotriene (LT) B
    Archambault AS; Poirier S; Lefebvre JS; Robichaud PP; Larose MC; Turcotte C; Martin C; Provost V; Boudreau LH; McDonald PP; Laviolette M; Surette ME; Flamand N
    J Leukoc Biol; 2019 Jun; 105(6):1131-1142. PubMed ID: 30676680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E; Schröder JM; Christophers E
    Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
    Hidi R; Coëffier E; Vargaftig BB
    J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method for the measurement of eosinophil migration.
    Håkansson L; Westerlund D; Venge P
    J Leukoc Biol; 1987 Dec; 42(6):689-96. PubMed ID: 2445885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils.
    Palmblad J; Gyllenhammar H; Lindgren JA; Malmsten CL
    J Immunol; 1984 Jun; 132(6):3041-5. PubMed ID: 6327816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From eosinophil chemotactic factor of anaphylaxis to leukotriene B4--chemistry, biology and functional significance of eosinophil chemotactic leukotrienes in dermatology.
    Czarnetzki BM; Rosenbach T
    Dermatologica; 1989; 179 Suppl 1():54-9. PubMed ID: 2550288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products.
    Czarnetzki BM; Mertensmeier R
    Prostaglandins; 1985 Jul; 30(1):5-11. PubMed ID: 2996056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA; Casale TB
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism.
    Muñoz NM; Douglas I; Mayer D; Herrnreiter A; Zhu X; Leff AR
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1398-403. PubMed ID: 9105085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro.
    Czarnetzki BM; Rosenbach T
    Prostaglandins; 1986 May; 31(5):851-8. PubMed ID: 3014612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene B4-activated human endothelial cells promote transendothelial neutrophil migration.
    Nohgawa M; Sasada M; Maeda A; Asagoe K; Harakawa N; Takano K; Yamamoto K; Okuma M
    J Leukoc Biol; 1997 Aug; 62(2):203-9. PubMed ID: 9261334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reevaluation of the chemotactic potency of leukotriene B4 (LTB4).
    Jubiz W
    Biochem Biophys Res Commun; 1983 Feb; 110(3):842-50. PubMed ID: 6301465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of leukotrienes B4 (LTB4) and D4 (LTD4) on motility of isolated normodense human eosinophils and neutrophils.
    Spada CS; Krauss AH; Nieves AL; Woodward DF
    Adv Exp Med Biol; 1997; 400B():699-706. PubMed ID: 9547621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC).
    Sigal CE; Valone FH; Holtzman MJ; Goetzl EJ
    J Clin Immunol; 1987 Mar; 7(2):179-84. PubMed ID: 3571436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation to chemotactic factor gradients to neutrophil migration and orientation under agarose.
    Udén AM; Hafström I; Palmblad J
    J Leukoc Biol; 1986 Jan; 39(1):27-35. PubMed ID: 3001211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.